• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Portola Pharmaceuticals Inc

+ Add to Watchlist

0PP:GR

18.265 EUR 0.0000.00%

As of 02:05:41 ET on 07/29/2014.

Snapshot for Portola Pharmaceuticals Inc (0PP)

Open: - Day's Range: - Volume: 0
Previous Close: 18.265 52wk Range: 14.464 - 22.645 1-Yr Rtn: +3.42%

Stock Chart for 0PP

No chart data available.
  • 0PP:GR 18.265
  • 1D
  • 1M
  • 1Y
18.265
Interactive 0PP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 0PP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -3.4100
Est. PEG Ratio -
Market Cap (M EUR) 751.08
Shares Outstanding (M) 41.12
30 Day Average Volume 25
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/15/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 0PP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 0PP

Portola Pharmaceuticals, Inc. provides specialty pharmaceutical products. The Company develops novel therapeutics for thrombosis, hematologic disorders, and inflammation indications. Portola Pharmaceuticals operates in the United States.

Charles J HomcyCo-Chairman/Co-FounderHollings C RentonCo-Chairman
William LisChief Executive OfficerMardi C DierExec VP/CFO
More Company Profile & Key Executives for 0PP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil